InsidersTradesSigma
Browse the detailed record of transactions filed by Lingamneni Anila, Chief Technology Officer. Officer active across 2 companies, notably Haemonetics CORP. Cumulatively, 5 filings have been recorded. Total volume traded: €87k. The latest transaction was disclosed on 19 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Anila Lingamneni is the Executive Vice President and Chief Technology Officer at Haemonetics Corp, a company specializing in medical technologies. In this role, she oversees technological development and innovation within the company.